Deepali Rishipathak - Dept Oncol Biomarker Dev, Genentech Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 23 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure S4 from Atezolizumab Plus Magrolimab, Niraparib, or Tocilizumab Versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Alexandra Drakaki,Peter Schmid,Aristotelis Bamias,Juan Martín-Liberal,Sang Joon Shin,Terence W. Friedlander, Diego Tosi,Chandler Park,Carlos Gomez‐Roca,Florence Joly,Daniel Castellano, Rafael Morales‐Barrera, Irene Moreno,Aude Fléchon,Kobe Yuen,Deepali Rishipathak,Kelly DuPree, Fiona Young,Francesca Michielin,Colby S. Shemesh, Elizabeth E. Steinberg,Patrick Williams, Jae‐Lyun Lee

openalex（2023）

Cited0Views0Bibtex

A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non–muscle-invasive Bladder Cancer

Brant A. Inman,Noah M. Hahn,Kelly Stratton,Ryan Kopp,Alex Sankin,Eila Skinner,Kamal Pohar,Benjamin A. Gartrell,Song Pham,Deepali Rishipathak,Sanjeev Mariathasan,Nicole Davarpanah,Corey Carter,Gary D. Steinberg

European Urology Oncologyno. 3 (2023): 313-320

Cited0Views0Bibtex

A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guerin in Patients with High-risk Non- Muscle-Invasive Bladder Cancer

European urology oncology（2023）

Cited2Views0WOSBibtex

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure S2 from Atezolizumab Plus Magrolimab, Niraparib, or Tocilizumab Versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

openalex

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn